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Table. Summary of endoleak channel ﬂow, radiographic detection of the endoleak, sac pressurization as mean arterial
pressure (MAP) and pulse pressure (PP)
Systemic MAP/
aneurysm MAP
(mm Hg)
Systemic PP/
aneurysm
PP (mm Hg)
Net endoleak
ﬂow (cc/min)
Standard angiography/
delayed imaging
(positive/negative
after 30 mins)
No endoleak 113/101 80/10 not applicable negative/negative
Type 1a endoleak
no outﬂow
116/120 84/17 1.27 negative/positive
Type 1a endoleak
with outﬂow
119/105.5 86/12 39 positive/positive
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Aortic Occlusion Hemodynamic Attenuation With
Valproic Acid
Marlin W. Causey, Seth Miller, Niten Singh, Matthew
Martin. Madigan Army Medical Center, Ft. Lewis, Wash
Objectives: Valproic acid (VPA; a histone deacetylase
inhibitor) has demonstrated signiﬁcant decreases in resusci-
tation requirements as well as minimizing pathologic phys-
iology following short term aortic occlusion. The purpose
of this study was to compare the cardiac and hemodynamic
changes with VPA administration following supraceliac
aortic occlusion.
Methods: 19 swine were exposed to a 35% blood
volume hemorrhage followed by a supraceliac aortic cross
clamp only model with valproic acid (400 mg/kg) admin-
istered as a drip continuously during supraceliac aortic cross
clamping (CC, n ¼ 9). Hemodynamics were measured
with the use of arterial blood pressure monitor and
a pulmonary artery thermodilution catheter.
Results: 10 swine were divided into two equal groups-
sham and model. In this validation, hemodynamics were
signiﬁcantly different as measured after hemorrhage and
cross clamp by mean arterial pressure (MAP; P ¼ .024),
heart rate (P < .001), cardiac index (CI; P ¼ .005). In
the comparison arm of control and cross clamp group,
there was a signiﬁcant attenuation in the adverse hemodya-
mic response with administration of VPA (n ¼ 9) during
cross clamp (MAP ¼ 87 6 28 vs CC-122 6 43 mm Hg;
P ¼ .02; HR ¼ 124 6 23 vs CC-161 6 32 bpm; P ¼
.01). Additionally, throughout the cross clamp application,
there was a signiﬁcantly decreased hyperdynamic response
with the administration of VPA (Fig).
Conclusions: VPA helps attenuate the adverse hyper-
dynamic cardiac response following a hemorrhagic event
and subsequent aortic occlusion. The hemodynamic
response appeared to be not only signiﬁcant at each time
interval, but sustained as cross clamp times increased. Addi-
tionally, VPA seemed to minimize pathologic hemody-
namic variation and provide cardiac protection through
minimizing cardiac stress and work of the heart during
aortic occlusion.Author Disclosures: M. W. Causey: Nothing to disclose;
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Preservation of Antegrade Internal Iliac Artery Flow
Using Heilical Branch Devices in Challenging
Anatomic Situations: Technical Succss, Survival and
Patency
Shen Wong, Roy K. Greenberg, Matthew J. Eagleton, Tara
Mastracci, Yuki Kuramochi. Vascular Surgery, Cleveland
Clinic Foundation, Cleveland, Ohio
Objectives: Technical success and patency of iliac
branch devices (IBD) for aortoiliac aneurysms are scarce
